FDA application for promising oral MS drug, BG-12

Discuss Tecfidera (BG-12, dimethyl fumarate) as an oral treatment for multiple sclerosis.

FDA application for promising oral MS drug, BG-12

Postby MSUK » Tue Feb 28, 2012 8:04 am


Biogen Idec Inc., a Weston-based biotechnology company known for its multiple sclerosis drugs, said it has submitted a New Drug Application to federal regulators to get approval to market a potential new MS treatment known as BG-12.

In December, Biogen Idec shares hit their high for 2011 after the company released promising results from a clinical trial of BG-12.

BG-12, the company’s designation for dimethyl fumarate, would be taken twice a day in pill form, and it is designed to treat of relapsing-remitting multiple sclerosis, sometimes called RRMS, the most common form of MS, Biogen Idec said in a press release.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1679
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Tecfidera (BG-12, dimethyl fumarate)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service